MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail

Cell Death and Disease

Volumn 6, Issue 11, 2015, Pages

  Zuo, Q F ^a   Cao, L Y ^a   Yu, T ^a   Gong, L ^a   Wang, L N ^a   Zhao, Y L ^a   Xiao, B ^a   Zou, Q M ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE 14; MESSENGER RNA; MICRORNA 22; TRANSCRIPTION FACTOR SNAIL; MICRORNA; MIRN22 MICRORNA, HUMAN; MMP14 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; OVERALL SURVIVAL; PERITONEUM METASTASIS; PHENOTYPE; PRIORITY JOURNAL; STOMACH CANCER; TUMOR INVASION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; GENETICS; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR; XENOGRAFT;

ANIMALS; CELL PROLIFERATION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FEMALE; HETEROGRAFTS; HUMANS; MATRIX METALLOPROTEINASE 14; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SNAIL FAMILY TRANSCRIPTION FACTORS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84989298902     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.297     Document Type: Article

References (42)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108.
2. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS et al. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25, 676, 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015; 385: 977-1010.
3. Cancer Genome Atlas Research N, Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014; 513: 202-209.
4. Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Familial gastric cancer: Genetic susceptibility, pathology, and implications for management. Lancet Oncol 2015; 16: E60-e70.
5. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
6. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005; 132: 4653-4662.
7. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-714.
8. Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J et al. MicroRNA dysregulation in gastric cancer: A new player enters the game. Oncogene 2010; 29: 5761-5771.
9. Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 2010; 20: 784-793.
10. Xia J, Wu Z, Yu C, He W, Zheng H, He Y et al. miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. J Pathol 2012; 227: 470-480.
11. Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis. Oncogene 2010; 29: 937-948.
12. Aigner A. MicroRNAs (miRNAs) in cancer invasion and metastasis: Therapeutic approaches based on metastasis-related miRNAs. J Mol Med (Berl) 2011; 89: 445-457.
13. Li Z, Cao Y, Jie Z, Liu Y, Li Y, Li J et al. miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett 2012; 323: 41-47.
14. Zhao X, Dou W, He L, Liang S, Tie J, Liu C et al. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 2013; 32: 1363-1372.
15. Zuo QF, Zhang R, Li BS, Zhao YL, Zhuang Y, Yu T et al. MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZbinding motif, TAZ. Cell Death Dis 2015; 6: E1623.
16. Li BS, Zuo QF, Zhao YL, Xiao B, Zhuang Y, Mao XH et al. MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival. Oncogene 2015; 34: 2556-2565.
17. Song SJ, Pandolfi PP. miR-22 in tumorigenesis. Cell Cycle 2014; 13: 11-12.
18. Wang X, Yu H, Lu X, Zhang P, Wang M, Hu Y. MiR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151. Biochem Biophys Res Commun 2014; 445: 175-179.
19. Guo MM, Hu LH, Wang YQ, Chen P, Huang JG, Lu N et al. miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1. Med Oncol 2013; 30: 542.
20. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-174.
21. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
22. Zarrabi K, Dufour A, Li J, Kuscu C, Pulkoski-Gross A, Zhi J et al. Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. J Biol Chem 2011; 286: 33167-33177.
23. Dong Y, Chen G, Gao M, Tian X. Increased expression of MMP14 correlates with the poor prognosis of Chinese patients with gastric cancer. Gene 2015; 563: 29-34.
24. de la Pena S, Sampieri CL, Ochoa-Lara M, Leon-Cordoba K, Remes-Troche JM. Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer. Dis Markers 2014; 2014: 285906.
25. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784.
26. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
27. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674.
28. Wang Y, Shi J, Chai K, Ying X, Zhou BP. The role of Snail in EMT and tumorigenesis. Curr Cancer Drug Targets 2013; 13: 963-972.
29. Shin NR, Jeong EH, Choi CI, Moon HJ, Kwon CH, Chu IS et al. Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. BMC Cancer 2012; 12: 521.
30. He H, Chen W, Wang X, Wang C, Liu F, Shen Z et al. Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci 2012; 103: 1296-1303.
31. Egawa N, Koshikawa N, Tomari T, Nabeshima K, Isobe T, Seiki M. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. J Biol Chem 2006; 281: 37576-37585.
32. Singh D, Srivastava SK, Chaudhuri TK, Upadhyay G. Multifaceted role of matrix metalloproteinases (MMPs). Front Mol Biosci 2015; 2: 19.
33. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development 2005; 132: 3151-3161.
34. Yang F, Hu Y, Liu HX, Wan YJ. MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor. J Biol Chem 2015; 290: 6507-6515.
35. Wan WN, Zhang YQ, Wang XM, Liu YJ, Zhang YX, Que YH et al. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer. Diagn Pathol 2014; 9: 178.
36. Ling B, Wang GX, Long G, Qiu JH, Hu ZL. Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3. J Cancer Res Clin Oncol 2012; 138: 1355-1361.
37. Pasqualini L, Bu H, Puhr M, Narisu N, Rainer J, Schlick B et al. miR-22 and miR-29a are members of the androgen receptor cistrome modulating LAMC1 and Mcl-1 in prostate cancer. Mol Endocrinol 2015; 29: E20141358.
38. Yang C, Ning S, Li Z, Qin X, Xu W. miR-22 is down-regulated in esophageal squamous cell carcinoma and inhibits cell migration and invasion. Cancer Cell Int 2014; 14: 138.
39. Song SJ, Poliseno L, Song MS, Ala U, Webster K, Ng C et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 2013; 154: 311-324.
40. Song SJ, Ito K, Ala U, Kats L, Webster K, Sun SM et al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 2013; 13: 87-101.
41. Tseng CW, Lin CC, Chen CN, Huang HC, Juan HF. Integrative network analysis reveals active microRNAs and their functions in gastric cancer. BMC. Syst Biol 2011; 5: 99.
42. Poincloux R, Lizarraga F, Chavrier P. Matrix invasion by tumour cells: A focus on MT1-MMP trafficking to invadopodia. J Cell Sci 2009; 122: 3015-3024.